Eli Lilly to Sell Weight-Loss Drugs Directly to Patients

January 5, 2024

3 hypodermic needles

(Axios) – Eli Lilly is poised to sell medicine directly to consumers — with an emphasis on newly popular weight-loss drugs — in a move toward cutting out the controversial middle players in drug distribution. Why it matters: Pharmaceutical companies typically aren’t in the business of selling their drugs to individuals — but the weight-loss drug boom is sufficiently lucrative to shake up the status quo. (Read More)